Bel Air Investment Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bel Air Investment Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$3.69M	Sell	27,291 -6,084	-18%	-$800K	0.11%	93
2021 Q1	$4.53M	Buy	+33,375	New	+$5M	0.14%	90

Other funds holding XBI

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Bel Air Investment Advisors's XBI Position: Q2 2021 in Review

Bel Air Investment Advisors reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 18% in Q2 2021, selling an estimated $800K and leaving 27,291 shares worth $3.69M. The position accounts for 0.11% of the portfolio, ranked #93.

Bel Air Investment Advisors first reported a position in XBI in Q1 2021 and has held it in 2 quarters since. The position peaked at $4.53M in Q1 2021. 663 funds tracked by Wall St. Rank hold XBI as of Q2 2021.

Bel Air Investment Advisors held 27,291 shares of State Street SPDR S&P Biotech ETF worth $3.69M as of Q2 2021.
Bel Air Investment Advisors sold 6,084 State Street SPDR S&P Biotech ETF shares in Q2 2021, an estimated $800K.
State Street SPDR S&P Biotech ETF made up 0.11% of Bel Air Investment Advisors's portfolio in Q2 2021, its #93 holding.
Bel Air Investment Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q1 2021 and has held it in 2 quarters since.
Bel Air Investment Advisors's State Street SPDR S&P Biotech ETF position peaked at $4.53M in Q1 2021.
663 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2021.

Based on Bel Air Investment Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.